Hiv Vaccine Trials Network

This early-stage study tested a new HIV vaccine in 34 healthy volunteers who did not have HIV. The goal was to see if the vaccine was safe and whether it triggered an immune response. Researchers used a chimpanzee virus to deliver the vaccine and a protein boost to try to teach t…

This study tested a new HIV vaccine in 38 healthy infants who were exposed to HIV at birth but did not get the virus. The goal was to see if the vaccine is safe and helps the babies' immune systems fight HIV. The vaccine was given along with a special ingredient to boost its effe…

This study examined the immune systems of 760 people who had recovered from COVID-19 to understand how their bodies fought the virus. Researchers measured antibodies and immune cells in blood samples over several months. The goal was to gather information that could improve tests…

This study looked at whether a lab-made antibody called VRC01 could help people with HIV control the virus without taking daily HIV medication. Thirteen people who got HIV during a vaccine study and had taken HIV drugs for at least a year stopped their medication under close moni…